Annotation Detail for ORM2


Gene Symbol: | ORM2 ( AGP-B,AGP-B',AGP2 ) |
---|---|
Gene Full Name: | orosomucoid 2 |
Band: | 9q32 |
Quick Links | Entrez ID:5005; OMIM: 138610; Uniprot ID:A1AG2_HUMAN; ENSEMBL ID: ENSG00000228278; HGNC ID: 8499 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of ORM2 mRNA | increases expression | 18648102 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ORM2 mRNA | affects expression | 17562736 15606129 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of ORM2 mRNA | decreases expression | 11264010 |
C109238 | acyline | acyline results in decreased expression of ORM2 mRNA | decreases expression | 17510436 |
C053342 | brevetoxin | brevetoxin analog results in decreased expression of ORM2 mRNA | decreases expression | 14529743 |
C019304 | ciprofibrate | ciprofibrate results in decreased expression of ORM2 mRNA | decreases expression | 12771043 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of ORM2 mRNA | decreases expression | 20106945 |
D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA | affects cotreatment|increases expression | 16054899 |
D003907 | Dexamethasone | EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of ORM2 mRNA | increases expression | 12771043 |
D011345 | Fenofibrate | Fenofibrate results in decreased expression of ORM2 mRNA | decreases expression | 11798191 |
D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA | affects cotreatment|increases expression | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ORM2 mRNA | increases expression | 17321000 |
C042763 | olive oil | olive oil analog affects the expression of ORM2 mRNA | affects expression | 17349074 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of ORM2 mRNA | decreases expression | 18467677 |
C023036 | perfluorooctanoic acid | PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of ORM2 mRNA] | decreases expression|increases reaction | 18467677 |
D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ORM2 mRNA] | affects reaction|increases expression | 19482888 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of ORM2 mRNA | increases expression | 19482888 19270015 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of ORM2 mRNA | decreases expression | 11798191 18467677 20059764 17321000 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of ORM2 mRNA | increases expression | 18445702 |
C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in decreased expression of ORM2 mRNA] | affects reaction|decreases expression | 17321000 |
C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ORM2 mRNA] | decreases expression|increases reaction | 20059764 18467677 |
C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA | affects cotreatment|increases expression | 16054899 |
C089730 | rosiglitazone | EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 8.27 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 8.27 | 15322242 11752688 14514962 | |
MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 8.98 | 11850527 18653653 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 8.98 | 18653653 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 6.63 | 3712494 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 6.63 | 6695378 10737359 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 24.82 | 16434500 19052882 18056438 17620307 17162532 19061943 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 24.82 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 24.82 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 24.82 | 16835633 | |
MESH:D000544 | Alzheimer Disease | rosiglitazone | 2.85 | 19621015 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.93 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.84 | 10982225 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 3.52 | 17659584 | |
MESH:D050197 | Atherosclerosis | olive oil | 4.32 | 16216721 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.42 | 18445737 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 5.02 | 1440618 11289319 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 8.71 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 8.71 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.79 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.75 | 15746008 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 1.97 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 1.97 | 20435547 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.78 | 16835633 | |
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 6.53 | 3581430 7296757 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 6.53 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 6.53 | 19335982 20727157 16698587 16569478 19171122 17055752 18971187 17162532 21159647 19383236 20512989 16502159 19394651 16328049 16288022 3084413 16830150 18665156 19519916 19208518 3581430 10672840 20524982 17761372 18978308 16681979 17173139 16878318 19822196 19701751 18506893 20432363 20007298 19919837 17428255 18210153 17138121 18788625 16807293 19107877 11831363 18056438 19418558 19052882 17978847 20214788 20935162 10737359 16540662 16935385 20084675 20101231 18785209 18393292 16779866 18494052 20514400 18691550 19539802 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 6.53 | 20007298 20935162 17173139 6705139 1701930 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 2.66 | 7296757 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.35 | 18850075 18670907 16120746 | |
MESH:D002318 | Cardiovascular Diseases | olive oil | 4.52 | 16216721 | |
MESH:D002386 | Cataract | Acetaminophen | 2.57 | 10977129 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 11.07 | 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 11.07 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 11.07 | 17174075 7505956 21159647 2727394 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 4.24 | 4080065 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 9.26 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 9.26 | 16835633 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 13.29 | 9022650 19486331 | |
MESH:D002779 | Cholestasis | Cyclosporine | 13.29 | 19486331 | |
MESH:D002779 | Cholestasis | pirinixic acid | 13.29 | 19176532 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 2.09 | 16354765 15668235 15340226 8697196 12621046 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 2.49 | 15824018 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 3.04 | 17141729 14669216 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 2.61 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.61 | 10048152 20055451 15322242 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 7.00 | 12868966 11298694 2524372 8970840 18759878 11906362 8156756 14531868 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 7.00 | 12438553 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 2.41 | 18249437 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 3.47 | 3621924 2952479 | |
MESH:D003920 | Diabetes Mellitus | rosiglitazone | 4.28 | 17446233 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 7.14 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 7.14 | 12642470 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 7.14 | 17107852 | |
MESH:D003967 | Diarrhea | Dexamethasone | 3.68 | 7237001 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 8.89 | 18648102 1440618 9653073 18289764 18692083 16192314 6482804 9022650 11289319 8291058 7440962 6679447 9328219 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 8.89 | 16781746 11287661 19370779 15968718 11743745 15619225 12705907 16109766 19164858 16227642 14725611 11834606 17562736 17522070 10663392 19085960 2444490 14986274 11461765 17906064 18071297 19420014 18713872 11421492 19923254 19416960 12392966 10915739 16393943 10774834 12540782 16177239 11739529 19739265 11529661 16081117 12153990 12958197 12594235 14550746 16485898 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 8.89 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 8.89 | 20420201 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 4.10 | 19426721 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.74 | 11462148 | |
MESH:D050171 | Dyslipidemias | Fenofibrate | 4.41 | 16707586 | |
MESH:D004421 | Dystonia | Phenobarbital | 3.99 | 1851702 | |
MESH:D004485 | Eczema | Dexamethasone | 4.44 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 21.49 | 19703484 | |
MESH:D004487 | Edema | perfluorooctanoic acid | 21.49 | 12083418 17259670 | |
MESH:D004487 | Edema | pirinixic acid | 21.49 | 12083418 | |
MESH:D004487 | Edema | rosiglitazone | 21.49 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 21.49 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.90 | 15322242 16714409 18230668 | |
MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 4.08 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 3.00 | 10568697 9294722 | |
MESH:D019446 | Endotoxemia | Lipopolysaccharides | 4.39 | 17637181 15328337 15821434 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 4.09 | 3659116 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 3.87 | 3922381 11558140 | |
MESH:D004827 | Epilepsy | Phenobarbital | 2.88 | 20417680 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 3.52 | 6401628 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 4.24 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 4.01 | 3659116 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 5.12 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 2.10 | 3581430 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 3.00 | 11564622 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 18.65 | 19224547 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 18.65 | 21071580 20387270 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 18.65 | 19236843 20131406 | |
MESH:D005234 | Fatty Liver | rosiglitazone | 18.65 | 19196556 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.44 | 11858732 | |
MESH:D005334 | Fever | Lipopolysaccharides | 3.99 | 9205823 11852909 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 5.02 | 6705139 | |
MESH:D005355 | Fibrosis | Cyclosporine | 8.44 | 12639820 12168785 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 8.44 | 20067830 | |
MESH:D005756 | Gastritis | Acetaminophen | 3.68 | 16983495 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 4.21 | 8708960 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 4.02 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.59 | 10696789 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 2.32 | 11294989 10048152 | |
MESH:D006333 | Heart Failure | pirinixic acid | 2.52 | 20558911 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 4.41 | 15720958 | |
MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 4.36 | 16366002 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.32 | 11000095 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 3.50 | 6705139 | |
MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 20.60 | 3609246 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 20.60 | 16109766 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 20.60 | 19176532 18467677 19772884 16221962 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 20.60 | 16120746 15340226 12621046 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 3.06 | 7520565 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 4.05 | 16959395 15340226 16354765 8697196 18606429 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 13.08 | 16870215 | |
MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 13.08 | 12083418 | |
MESH:D006930 | Hyperalgesia | rosiglitazone | 13.08 | 12083418 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 3.16 | 20558911 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 3.92 | 15034207 | |
MESH:D006973 | Hypertension | Cyclosporine | 8.54 | 10903974 | |
MESH:D006973 | Hypertension | Dexamethasone | 8.54 | 17042910 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 8.54 | 18670907 18850075 | |
MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 5.44 | 18306037 | |
MESH:D007249 | Inflammation | Dexamethasone | 19.86 | 8960868 11099482 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 19.86 | 18785209 | |
MESH:D007249 | Inflammation | Lipopolysaccharides | 19.86 | 17237260 9205823 12878042 17255318 17963957 | |
MESH:D007249 | Inflammation | perfluorooctanoic acid | 19.86 | 12083418 | |
MESH:D007249 | Inflammation | rosiglitazone | 19.86 | 12083418 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 19.86 | 12200463 12878042 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 7.46 | 16306350 | |
MESH:D007333 | Insulin Resistance | rosiglitazone | 7.46 | 16306350 | |
MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 4.61 | 17255318 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 5.02 | 9022650 8074119 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 3.32 | 16580747 | |
MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 5.44 | 18306037 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 4.44 | 15604871 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 5.75 | 12587719 15629191 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 5.75 | 18776723 10903974 8314463 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 7.21 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 7.21 | 12371664 | |
MESH:D007970 | Leukopenia | Lipopolysaccharides | 4.69 | 15821434 | |
MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 5.22 | 8812269 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 6.60 | 19638242 20032147 18665156 18522880 18407596 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 6.60 | 21047994 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 3.18 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 8.73 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 8.73 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 8.73 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 8.73 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 8.73 | 17347453 15980055 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 8.73 | 12878042 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 6.45 | 12587719 19784758 19460945 12969438 16610002 19014921 16611625 11587558 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 6.45 | 17034775 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 6.45 | 19363144 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 3.22 | 16871587 17185352 | |
MESH:D008113 | Liver Neoplasms | ciprofibrate | 21.81 | 12771043 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 21.81 | 15885732 20405173 18648771 19996281 19426721 19499222 20434301 19833225 20101389 10737359 20118626 12112319 19254457 21278145 18978307 19256749 15175105 19427195 19812893 21167192 18644402 12771043 19850985 21071580 19551842 19073162 20501860 2422723 19690152 19255062 18754104 19638242 19294768 20583210 18977376 19090486 20452335 20137499 21047994 16942905 9163691 2862719 20492335 19642983 | |
MESH:D008113 | Liver Neoplasms | Fenofibrate | 21.81 | 18978307 | |
MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 21.81 | 18709148 14757943 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 21.81 | 19482888 8742319 15975961 19073162 21047994 19812893 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 21.81 | 20007298 16377806 15890375 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 21.81 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 18.53 | 6587162 1399818 3712494 598648 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 18.53 | 16842330 17854601 18079962 19539802 19126423 17174075 18775883 18544905 17942915 19004024 19519916 21159647 18282651 19009564 3124819 16267830 2563599 18308698 9362446 18253720 18164116 18093689 | |
MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 18.53 | 18775883 18253720 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 18.53 | 18308698 6150874 2563599 17172636 1399818 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 18.53 | 12151625 | |
MESH:D055370 | Lung Injury | Lipopolysaccharides | 3.99 | 21114838 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 3.43 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 3.43 | 6695378 20970405 20512841 21163286 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 3.43 | 11884234 19555203 | |
MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 3.38 | 16827153 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.55 | 19513568 | |
MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 4.36 | 17261469 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.79 | 16801185 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 3.49 | 15867202 16118317 15744524 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 3.49 | 16239165 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 3.53 | 9809623 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 2.13 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 3.00 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 2.93 | 16411023 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 4.47 | 17484760 | |
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 5.67 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 5.67 | 3581430 9029167 | |
MESH:D009369 | Neoplasms | pirinixic acid | 1.94 | 17405874 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 4.44 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.27 | 19348381 18481113 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 3.20 | 14600291 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 2.90 | 6679447 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 8.12 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 8.12 | 20387270 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 5.12 | 20387270 | |
MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 4.94 | 9802331 | |
MESH:D009765 | Obesity | pirinixic acid | 1.81 | 20558911 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 3.40 | 6482804 4026338 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 5.02 | 3988306 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 4.36 | 17016548 | |
MESH:D010146 | Pain | Acetaminophen | 2.37 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 5.24 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 5.24 | 16965848 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 3.47 | 7296757 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.25 | 12520081 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 4.47 | 6228378 | |
MESH:D011014 | Pneumonia | Lipopolysaccharides | 4.55 | 12224865 11605937 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.54 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 15.17 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 15.17 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 15.17 | 2563599 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 3.53 | 21297632 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 9.64 | 17132714 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 9.64 | 11118676 11399792 11896295 11222880 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 4.50 | 12752131 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.22 | 16882103 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 2.38 | 19058328 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 4.00 | 18379247 11700416 | |
MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 3.72 | 10835634 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.82 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 3.36 | 3692021 | |
MESH:D012640 | Seizures | Phenobarbital | 2.68 | 16876388 3137016 4039156 11442880 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 4.81 | 6407741 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 2.03 | 16192470 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 4.31 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 1.75 | 18456281 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 7.85 | 15138204 | |
MESH:D013276 | Stomach Ulcer | olive oil | 7.85 | 16252198 12498302 | |
MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 4.15 | 15821434 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.90 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 11.86 | 7505956 1399818 6587162 3712494 6582329 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 11.86 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 11.86 | 1399818 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 2.27 | 8074119 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.96 | 10982225 | |
MESH:D014605 | Uveitis | Cyclosporine | 11.77 | 1336536 | |
MESH:D014605 | Uveitis | Dexamethasone | 11.77 | 1336536 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.59 | 12125929 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.25 | 15886252 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 4.44 | 17120751 |
No data |